Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
A breakdown product of red blood cells; reflects liver processing capacity. Bilirubin (total) is measured by blood test as part of the Organ panel in the HodieLabs Health Blueprint.
Gilbert syndrome (benign unconjugated hyperbilirubinaemia) affects ~5–10% of the population and is harmless. Mildly elevated bilirubin has antioxidant properties and is associated with lower cardiovascular risk.
Associated risks when out of range: Liver/biliary issues when elevated, Haemolysis/Gilbert’s (contextual).
The HodieLabs Evidence-Based Clinical Library classifies Bilirubin (total) as an strong evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is RCPA Australian pathology reference intervals; total bilirubin <20 umol/L normal. Mildly elevated (Gilbert syndrome) not pathological. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.
The HodieLabs Evidence-Based Clinical Library interprets Bilirubin (total) against published clinical authority standards, never arbitrary "optimal" ranges. Measured in µmol/L:
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
Bilirubin (total) is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. RCPA Australian pathology reference intervals; total bilirubin <20 umol/L normal. Mildly elevated (Gilbert syndrome) not pathological.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
A breakdown product of red blood cells; reflects liver processing capacity.
The HodieLabs Evidence-Based Clinical Library optimal range is <20 µmol/L, based on RCPA Australian pathology reference intervals; total bilirubin <20 umol/L normal. Mildly elevated (Gilbert syndrome) not pathological.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: mild elevation (gilbert syndrome) is benign and may be cardioprotective, investigate if >35 µmol/l with abnormal liver enzymes, may indicate hepatobiliary disease. Interpretation and an action plan should always involve your doctor.
Bilirubin (total) is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
Bilirubin (total) and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.